News und Analysen

Is it worth it to buy a stock after it experiences significant market gains? The answer is, it depends. Some companies don't have much growth fuel left in the tank after a nice run, while others

One formula to generate strong returns on equity markets involves investing small amounts of money in top stocks regularly over long periods. Buying fractional shares is one way to apply this

In today's video, I discuss recent updates impacting Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and other semiconductor stocks. To learn more, check out the short video, consider

Regardless of the number of tools and resources available to Wall Street or the average investor, there's no way to predict how a stock's price will move with 100% certainty.

However, one thing that

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.

Nektar Therapeutics (NASDAQ: NKTR) saw its stock price erode on Thursday, following the company's closing of a secondary stock issue. Investors gave the company a thumbs-down on the news by selling

AstraZeneca (NASDAQ: AZN) might soon be on the hook for an eventual 11-figure payout, and investors weren't all that comfortable with this. A Bloomberg article published Thursday morning said that

One day before the July Fourth holiday, the stock of clinical-stage biotech Summit Therapeutics (NASDAQ: SMMT) exploded like a powerful fireworks display. Shares of the cancer-focused company leaped

There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues that predate this year. Take, for instance, CRISPR Therapeutics

When it comes to your hard-earned money, you have a lot of choices about where to spend it. If your physician prescribes a new branded drug, though, you and your insurance company have few options.

Shares of UnitedHealth Group (NYSE: UNH) are falling today, down 4.5% as of 2:41 p.m. ET. The drop comes as the S&P 500 (SNPINDEX: ^GSPC) gained 0.3% and the Nasdaq Composite (NASDAQINDEX: ^IXIC)

Palantir Technologies is on an unstoppable tear. Even after a strong performance in 2024 where it soared 341%, it's up another 78% so far this year. Every time it seems the stock may be running out

Hims & Hers (NYSE: HIMS) and UnitedHealth (NYSE: UNH) suffered huge stock price decreases that attracted investors looking to buy the dip.

*Stock prices used were the afternoon prices of June 28

The threat of tariffs and trade wars sank many stocks back in April, but the market managed a sharp turnaround since then, reminiscent of the brief pandemic crash five years earlier. Many stocks are

There are a lot of healthcare companies that are investing in GLP-1 weight loss drugs. Today, the leaders in that space are Eli Lilly and Novo Nordisk. But it could get much more crowded in the

Following quite encouraging news from the laboratory on Monday, Amgen (NASDAQ: AMGN) was something of a stock market favorite the following day. Its shares closed the trading session more than 4%

Trading in AstraZeneca's (NASDAQ: AZN) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a U.S. exchange. Investors clearly

Over the past year, Apple (NASDAQ: AAPL) and Amgen (NASDAQ: AMGN), two well-established companies that are part of the iconic Dow Jones Industrial Average, have faced significant headwinds. Apple is

When it comes to popular healthcare stocks, investors have focused a lot of attention lately on Eli Lilly and Novo Nordisk and the potential of their blockbuster weight management treatments

As the old saying goes, "Sometimes, it's better to be lucky than to be good."

Take investors in the Voyager Technologies (NYSE: VOYG) initial public offering (IPO), for example. Once upon a time

What's the biggest misconception about investing? The idea that you need a lot of money to get started is certainly a contender. The reality is that it doesn't take much up-front cash.

Three

Spending on artificial intelligence (AI) infrastructure continues to rise, setting the stage for companies in the AI chip space to outperform over the coming years. The growth in AI infrastructure

Make no mistake, investors love revenue growth, and investing in companies that are growing their top lines quickly can be quite rewarding. 

Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: